Lonza entered into a definitive agreement for the sale of the Capsules & Health Ingredients (CHI) business to Lone Star Funds, at an enterprise value of CHF 2.3 billion (USD 3 billion). In connection with the deal
Tags :Linklaters
Swiss healthcare company Novartis, acting through one of its wholly-owned indirect subsidiaries, completed the acquisition of RNA therapeutics specialist Avidity Biosciences, for a total value of approximately USD 12 bn. In connection with the deal, Homburger
Niederer Kraft Frey (“NKF”) advised the underwriter and tokenisation agent on a CNY cross-border tokenised financing transaction of Ant Digital Technologies. NKF, alongside Linklaters as international counsel, provided comprehensive support throughout the transaction from a
Last December 2022, C+F Confectionery and Foods and Perfetti Van Melle Group announced that Perfetti Van Melle, the owner of confectionary brands such as Chupa Chups and Mentos, has entered into definitive agreements to acquire
Global investment firm Carlyle has entered into a definitive agreement to acquire AutoForm, the global provider of engineering software for sheet metal forming simulation and Body in White (BiW) assembly simulation, primarily used in the
Bratschi advised the Adecco Group on the 2021 update of the EUR 3,5 billion Euro Medium Term Note Programme. Bratschi advised the company with a team led by Thomas Peter (pictured) and composed by Christian Stambach (both
Walder Wyss acted as legal counsel to Montana Aerospace, in its initial public offering (IPO) at the SIX Swiss Exchange. This IPO has been one of the first to take place under the new Swiss
SIX Group could extend the offer period for Bolsas y Mercados Españoles (BME) as the coronavirus crisis poses tendering issues for retail investors, according to sources heard by Mergermarket
The Spanish government has authorised SIX Group’s takeover offer for the Spanish stock exchange operator Bolsas y Mercados Españoles (BME).
